Is PCRAF or ORCC a better dividend investment in 2026?

PCRAF currently yields 7181.33% with a 5% 5-year dividend growth rate. ORCC yields 9.79% with 5% growth. The better choice depends on your goal: PCRAF offers higher current income.

What is the dividend yield difference between PCRAF and ORCC?

PCRAF has a forward dividend yield of 7181.33% ($2.00/share annually). ORCC yields 9.79% ($1.32/share annually). The yield gap is 7171.54 percentage points.

Home › Compare › PCRAF vs ORCC

PCRAF vs ORCC: Dividend Comparison 2026

PCRAF yields 7181.33% · ORCC yields 9.79%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PCRAF wins by $2129323467795842.25M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PCRAF

● Live price

7181.33%

Share price

$0.03

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2129323467795842.25M

Annual income

$2,072,550,944,745,044,800,000.00

Full PCRAF calculator →

ORCC

● Live price

9.79%

Share price

$13.48

Annual div

$1.32

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.4K

Annual income

$1.04

Full ORCC calculator →

Portfolio growth — PCRAF vs ORCC

📍 PCRAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PCRAF	ORCC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PCRAF + ORCC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PCRAF pays

ORCC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PCRAF

Annual income on $10K today (after 15% tax)

$610,412.93/yr

After 10yr DRIP, annual income (after tax)

$1,761,668,303,033,288,000,000.00/yr

ORCC

Annual income on $10K today (after 15% tax)

$832.34/yr

After 10yr DRIP, annual income (after tax)

$0.88/yr

At 15% tax rate, PCRAF beats the other by $1,761,668,303,033,288,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PCRAF + ORCC for your $10,000?

PCRAF: 50%ORCC: 50%

100% ORCC50/50100% PCRAF

Portfolio after 10yr

$1064661733897921.13M

Annual income

$1,036,275,472,372,522,400,000.00/yr

Blended yield

97.33%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

PCRAF

No analyst data

Altman Z

-16.9

Piotroski

0/9

ORCC

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$16.00

+18.7% upside vs current

Range: $16.00 — $16.00

Altman Z

0.5

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PCRAF buys

ORCC buys

No recent congressional trades found for PCRAF or ORCC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPCRAFORCC

Forward yield	7181.33% ✓	9.79%
Annual dividend / share	$2.00 ✓	$1.32
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0% ✓	-50%
Portfolio after 10y	$2129323467795842.25M ✓	$21.4K
Annual income after 10y	$2,072,550,944,745,044,800,000.00 ✓	$1.04
Total dividends collected	$2125520801706147.50M ✓	$1.0K
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: PCRAF vs ORCC ($10,000, DRIP)

Year	PCRAF Portfolio	PCRAF Income/yr	ORCC Portfolio	ORCC Income/yr	Gap
1← crossover	$728,833	$718,132.85	$11,190	$489.61	+$717.6K → PCRAF
2	$49,695,629	$48,915,777.42	$12,229	$256.01	+$49.68M → PCRAF
3	$3,170,308,012	$3,117,133,689.10	$13,216	$130.74	+$3170.29M → PCRAF
4	$189,238,958,407	$185,846,728,834.15	$14,207	$66.02	+$189238.94M → PCRAF
5	$10,570,133,462,966	$10,367,647,777,471.07	$15,234	$33.17	+$10570133.45M → PCRAF
6	$552,520,748,327,293	$541,210,705,521,919.44	$16,317	$16.62	+$552520748.31M → PCRAF
7	$27,030,543,997,490,970	$26,439,346,796,780,764.00	$17,468	$8.32	+$27030543997.47M → PCRAF
8	$1,237,774,696,255,956,700	$1,208,852,014,178,641,400.00	$18,695	$4.16	+$1237774696255.94M → PCRAF
9	$53,058,432,757,754,490,000	$51,734,013,832,760,615,000.00	$20,006	$2.08	+$53058432757754.47M → PCRAF
10	$2,129,323,467,795,842,200,000	$2,072,550,944,745,044,800,000.00	$21,407	$1.04	+$2129323467795842.25M → PCRAF

PCRAF vs ORCC: Complete Analysis 2026

PCRAF — Stock

Pucara Gold Ltd. engages in the acquisition, exploration, and evaluation of mineral properties in Peru. The company explores for gold, copper, zinc, lead, and silver deposits. Its project portfolio includes the Lourdes, Pacaska, Capricho, Guadalupe, Keyla, Paco Orco, Pucapaca, and Santo Tomas Projects located in Peru. Pucara Gold Ltd. is based in Vancouver, Canada.

Full PCRAF Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →

📬

Get this PCRAF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PCRAF vs SCHD PCRAF vs JEPI PCRAF vs O PCRAF vs KO PCRAF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.